Aktuellt
SENASTE
Redeye returns with a more in-depth take of the Q3’21 report, which reflected a relatively neutral financial development. We have downed our sales estimates for the coming years due to a continuous uncertainty in elective surgery capacities and reconsiderations of contribution from the VA program in the shorter term – this poses a slight reassessment to our fair value range.
LÄS MER
